Guo‐Ming Shi
- Molecular Biology top 5%
- Cancer Research top 1%
- Oncology top 5%
- Hepatology top 2%
- Surgery top 10%
- Co-authors
- Ai‐Wu KeJia FanJiabin CaiJia‐Cheng LuXiaoyong HuangPengfei ZhangChao GaoJian Zhou
- Topics
- Cholangiocarcinoma and Gallbladder Cancer Studies (24 papers)Hepatocellular Carcinoma Treatment and Prognosis (16 papers)Peptidase Inhibition and Analysis (9 papers)
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Guo‐Ming Shi
69 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Molecular Biology 1.8k
- Cancer Research 1.2k
- Oncology 740
- Hepatology 483
- Surgery 446
Countries citing papers authored by Guo‐Ming Shi
This map shows the geographic impact of Guo‐Ming Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo‐Ming Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo‐Ming Shi more than expected).
Fields of papers citing papers by Guo‐Ming Shi
This network shows the impact of papers produced by Guo‐Ming Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo‐Ming Shi. The network helps show where Guo‐Ming Shi may publish in the future.
Co-authorship network of co-authors of Guo‐Ming Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Guo‐Ming Shi. A scholar is included among the top collaborators of Guo‐Ming Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guo‐Ming Shi. Guo‐Ming Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 9 | |
| 4 | 14 | |
| 5 | Down-regulation of USP8 Inhibits Cholangiocarcinoma Cell Proliferation and Invasion | 4 |
| 6 | 34 | |
| 7 | Circulating Tumor Cells as a Biomarker to Assist Molecular Diagnosis for Early Stage Non-Small Cell Lung Cancer | 3 |
| 8 | 8 | |
| 9 | 11 | |
| 10 | 178 | |
| 11 | Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinomabreakdown → | 465 |
| 12 | 45 | |
| 13 | 46 | |
| 14 | 45 | |
| 15 | 24 | |
| 16 | 35 | |
| 17 | 39 | |
| 18 | 129 | |
| 19 | 49 | |
| 20 | 184 |
About Guo‐Ming Shi
Guo‐Ming Shi is a scholar working on Hepatology, Cancer Research and Oncology, having authored 71 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (24 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers) and Peptidase Inhibition and Analysis (9 papers). The work is most often cited by research in Cancer Research (1.2k citations), Hepatology (483 citations) and Immunology and Allergy (183 citations). Guo‐Ming Shi has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Ai‐Wu Ke, Jia Fan, Jiabin Cai, Jia‐Cheng Lu, Xiaoyong Huang, Pengfei Zhang, Chao Gao, Jian Zhou, Zhen‐Bin Ding and Xiaojun Guo. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.